BioMarin Pharmaceutical (BMRN) gapped open lower Monday and has been declining for the bulk of early trade. The stock is now down 0.97 at $18.52.
BioMarin Pharmaceutical has dropped below a trading range and has set over a month and a half low. The stock has also fallen beneath its 50-day moving average.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.